✓Expert Reviewed📅Updated April 2026🔒Independently Researched
MEDVi vs Willow
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
7.2
MEDVi
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
CompoundedSemaglutideTirzepatide
Visit MEDVi →7.2
Willow
Best for mainstream telehealth GLP-1 accessStarting at $299/mo
CompoundedSemaglutideTirzepatide
Visit Willow →Side-by-Side Comparison
| Feature | MEDVi | Willow |
|---|---|---|
| Overall Score | 7.2/10 | 7.2/10 |
| Starting Price | ✓$179/mo | $299/mo |
| Customer Rating | — | — |
| Features | 3 features | 3 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
MEDVi
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Willow
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Our Verdict
Both MEDVi and Willow score equally well overall — the right choice depends on your priorities. Choose MEDVi if you want mainstream telehealth GLP-1 access, or Willow if mainstream telehealth GLP-1 access matters most to you.